pantethine has been researched along with selenomethionine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, W; Chumak, V; Gurinovich, V; Heffeter, P; Lehka, L; Moiseenok, A; Omelyanchik, S; Panchuk, R; Skorokhyd, N; Stoika, R | 1 |
Chumak, VV; Gurinovich, VA; Kozak, YS; Lehka, LV; Moiseenok, AG; Omelyanchik, SN; Panchuk, RR; Skorokhyd, NR; Stoika, RS | 1 |
Kozak, YS; Lehka, LV; Moiseenok, AG; Panchuk, RR; Skorokhyd, NR; Stoika, RS | 1 |
3 other study(ies) available for pantethine and selenomethionine
Article | Year |
---|---|
Specific antioxidant compounds differentially modulate cytotoxic activity of doxorubicin and cisplatin: in vitro and in vivo study.
Topics: Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Cisplatin; Doxorubicin; Drug Synergism; HCT116 Cells; HL-60 Cells; Humans; Jurkat Cells; Male; Oxidation-Reduction; Oxidoreductases; Pantetheine; Rats; Rats, Wistar; Selenomethionine; Sodium Selenite; Tumor Cells, Cultured | 2014 |
Antioxidants selenomethionine and D-pantethine decrease the negative side effects of doxorubicin in NL/Ly lymphoma-bearing mice.
Topics: Alanine Transaminase; Animals; Antineoplastic Agents; Antioxidants; Aspartate Aminotransferases; Doxorubicin; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Liver; Lymphoma; Male; Mice; Mice, Inbred BALB C; Pantetheine; Selenomethionine; Tumor Cells, Cultured | 2016 |
Tissue-protective activity of selenomethionine and D-panthetine in B16 melanoma-bearing mice under doxorubicin treatment is not connected with their ROS scavenging potential.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Dose-Response Relationship, Drug; Doxorubicin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Pantetheine; Reactive Oxygen Species; Selenomethionine | 2017 |